Demonstrates Union Square Advisors’ extensive platform in providing comprehensive advisory services to leading companies in the pharma technology sector
On September 17, 2025, Union Square Advisors announced that it served as the exclusive financial advisor to Scientist.com, the AI-powered R&D orchestration platform, in its sale to GHO Capital.
Scientist.com is a market-leading digital platform for outsourced R&D, trusted by leading global biopharma companies and thousands of pre-vetted suppliers of research services and products. The company’s innovative platform streamlines the entire outsourced research process through its powerful platform – from supplier qualification and compliance enforcement to intelligent vendor matching, automated contract drafting, predictive project modeling and smart negotiation tools – all within one seamless ecosystem.
“GHO’s expertise across our key market segments and track record of scaling innovative leaders make them the ideal partner to help us scale globally,” Kevin Lustig, PhD, and Chris Petersen, Founders of Scientist.com, commented. “Together, we can put outsourced research ‘on rails’, delivering shorter timelines, stronger governance and clearer visibility from concept to clinic.”
Edward de Nor and Stuart Quin, Partners at GHO, commented, “The alignment between our expertise in pharmaceutical R&D, biotechnology and life science tools, and Scientist.com’s market leadership, creates a unique opportunity to accelerate its growth. We are excited to partner with the team to expand global adoption and advance innovation, in line with our mission to deliver better, faster, more accessible healthcare.”
“Union Square Advisors is incredibly pleased to have partnered with the Scientist.com team on this transformative transaction with GHO Capital. This deal exemplifies our deep expertise in advising disruptive platforms that are revolutionizing regulated industries and further strengthens our position advising leading companies within the pharma technology sector,” said Carter McClelland, Chairman at Union Square Advisors.
For more information, read the full press release here.
